Vancouver, British Columbia--(Newsfile Corp. - December 13, 2018) - Wolverine Technologies Corp. (OTC Pink: WOLV) today provided the following update on the Chalk/DZI litigation.
Dr. Chalk continues to pursue his lawsuit against Decision-Zone Inc. ("DZI"), Rajeev Bhargava, and Nalini Bhargava for, among other things, oppression of him in his capacity as an officer and shareholder of DZI (the "Oppression Action"). As set out in the Statement of Claim, central to this oppression has been the actions by the Defendants to deny Dr. Chalk access to documents that would reveal the state of affairs of DZI, and the actions of Rajeev and Nalini Bhargava in doing so. This includes the apparent incorporation, without the full knowledge or oversight of the DZI Board of Directors, of a US-based subsidiary and licensing or assignment of rights of DZI technology to it. This refusal to provide documentation has now extended to the litigation itself, with the defendants having refused to list or produce whole categories of relevant and material documents despite their obligation to do so. Counsel for Dr. Chalk will shortly be setting down dates for the examination for discovery of Rajeev Bhargava in the Oppression Action with the goal of compelling production of relevant and material documents in the litigation, as well as the larger goal of uncovering the true state of affairs of DZI.
On Behalf of the Board
For further information please contact:
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, statements regarding the Chalk/Decision-Zone litigation.
Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with technology development and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.